Inflammation inhibitor blocks neurodevelopmental disorders in mouse model

neuron
Credit: CC0 Public Domain

Work published this week in the journal Proceedings of the National Academy of Sciences shows that an enzyme inhibitor developed by Professor Bruce Hammock and colleagues at UC Davis reduced inflammation in the brains of mice born to mothers with maternal immune activation. Inflammation triggered by the enzyme, soluble epoxide hydrolase, is linked to neurodevelopmental disorders in these mice.

"Inhibiting that enzyme stops the inflammation and the development of autism-like and schizophrenia-like symptoms in animal models," said co-author Kenji Hashimoto, a professor with the Chiba University Center for Forensic Mental Health, Japan.

The work flows from the idea that development of disorders such as autism or schizophrenia can be influenced by infections during pregnancy that expose the developing fetus to inflammatory chemicals. These disorders also have a strong genetic component.

By inhibiting soluble epoxide hydrolase, the researchers reversed cognitive and social interaction deficiencies in the mice pups. This might be due to an increase in natural brain chemicals that prevent brain inflammation.

Maternal immune response and autism

"There is mounting evidence that inappropriate maternal immune responses during pregnancy to infection contributes elevated risk to , at least in a fraction of cases," said Isaac Pessah, distinguished professor of molecular biosciences and associate dean of research and graduate education at the UC Davis School of Veterinary Medicine. Pessah was not involved in the study.

The findings show that a mouse model of some of the symptoms in autistic children can be suppressed by inhibiting soluble epoxide hydrolase, a target not previously explored, Pessah said.


Explore further

Soluble epoxide hydrolase in mammals diminishes the body's ability to self-repair

More information: Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation, Proceedings of the National Academy of Sciences (2019). DOI: 10.1073/pnas.1819234116 , https://www.pnas.org/content/early/2019/03/18/1819234116
Provided by UC Davis
Citation: Inflammation inhibitor blocks neurodevelopmental disorders in mouse model (2019, March 19) retrieved 18 October 2019 from https://medicalxpress.com/news/2019-03-inflammation-inhibitor-blocks-neurodevelopmental-disorders.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
80 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more